Gaingels

Jennifer has over 20 years of experience in finance and banking working at large institutions such as Credit Suisse, Bear Stearns and JP Morgan earning the coveted position of Executive Director. She has a wide array of experience, both loc…

Paul is the co-founder of Gaingels and Mathison.io, with David Beatty. To date, Gaingels has invested $110,000,000+ in 200+ companies since 2016, including $80m+ in the 2020 year. Paul also founded blue jay syndicate, now part of the Gainge…

Lorenzo is a serial entrepreneur and investor at the intersection of technology, art, commerce, and social value. He is a Tony-award winning Broadway producer and co-founder/CEO of the social edge, previously co-founded Powerset (exited to…

Peter has honed his expertise in website UX/UI, human-computer interaction, user analytics, SEO, and online communities for 25 years. He headed product development at Zagat, Vindigo, and was one of Meetup's very first employees. From 2003 t…

Max has always been an avid tech-enthusiast, fascinated by its novel creations and how they can improve our world. After graduating from Dartmouth, Max founded an e-commerce startup and subsequently started angel investing. He joined Gainge…

Emilie is an active angel investor and early Gaingels member, holding a PHD in economics sociology. She led strategy and transformation at Goldman Sachs and Bridgewater Associates, and a successful turnaround of a healthcare consulting comp…

Zachary is the founder and general partner at Calm Ventures, a Los Angele based venture capital firm that invests in companies from seed to pre-IPO. Prior to Calm, Zachary was an investor at OCV Partners, a $260M growth equity fund. Zach ha…

Jason is a tech, media & music executive with experience at leading corporations and startups including Google, Viacom, Disney, Deezer & 88rising. He is Vice President at 88rising, leading business development & partnerships. Previously, he…

Chris Leiter is the Founder & General Partner of Atria Ventures. Atria partners with founders reimagining the life sciences. We invest early, at inception and seed stages, in bold ideas at the nexus of technology and biology.